GeneDx Holdings Corp
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 11 →Insiders6 insiders bought $106.6M in 34 open-market buys. 4 insiders sold $20.0M, 8 of 95 sales on a 10b5-1 plan.→HoldersCorvex 16.1%Casdin Capital 12.4%BlackRock 5.7%→PeersClosest companies: PSNL, BDSX, GH→
From the filings
Figures
- Revenue
- $454.4Mlast 12 months
- Net income
- −$106.3Mlast 12 months
- Operating cash flow
- −$9.3Mlast 12 months
- Cash and equivalents
- $60.3Mat the last balance sheet
- Total debt
- $96.8Mat the last balance sheet
- Shares outstanding
- 29.8M shareson issue